ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1164508
BOSTON, MA
Position in AMRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,794,660
-$718,249 QoQ
Shares Held
334,758
-36.1% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 311 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. AMRX ranks #15 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,137,442 | $225,456,582 | |
| 2 | VTRS |
Viatris Inc
|
8,371,218 | $132,934,941 | |
| 3 | HLN |
Haleon plc
|
14,181,817 | $132,316,352 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,642,086 | $67,374,788 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
957,514 | $61,233,020 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,732,924 | $59,838,771 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
562,016 | $46,523,684 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,872,157 | $46,073,783 |
All Filings in AMRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,794,660 | 334,758 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,512,909 | 523,967 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $13,739,342 | 1,090,424 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $12,990,597 | 1,297,762 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,730,550 | 1,697,225 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $15,029,136 | 1,793,453 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $12,205,179 | 1,541,058 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $17,213,905 | 2,068,979 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,075,796 | 799,338 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,829,362 | 631,908 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,284,861 | 211,674 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,386,921 | 802,588 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,830,219 | 912,974 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $946,613 | 681,017 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $989,973 | 497,474 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $1,456,664 | 349,320 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $970,291 | 202,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $487,488 | 91,290 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,275,699 | 249,160 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,444,090 | 511,752 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $443,146 | 114,213 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,136,030 | 1,289,082 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $693,435 | 199,263 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||